Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia

Background: Fluoropyrimidine toxicity is often due to variations in the gene (DPYD) encoding dihydropyrimidine dehydrogenase (DPD). DPYD genotyping can be used to adjust doses to reduce the likelihood of fluoropyrimidine toxicity while maintaining therapeutically effective drug levels.Methods: A mul...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Angela Wu, Helen Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J. D. Ross, Bruce C. Carleton
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-09-01
coleção:	Frontiers in Pharmacology
Assuntos:	adverse drug reactions clinical implementation DPYD fluoropyrimidine toxicity pharmacogenetics
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1257745/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!